Can a website bring BRCA testing to more people?

NCT ID NCT03351803

Ongoing Knowledge-focused Sponsor: Memorial Sloan Kettering Cancer Center Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is testing a digital health tool to help more people of Ashkenazi Jewish descent get tested for BRCA gene mutations, which increase cancer risk. Over 5,400 participants will use a web portal to learn about testing and decide whether to proceed. The goal is to see if this approach can make genetic testing a routine part of healthcare.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Digital health solution (web portal for genetic testing access)
What this could lead to: If successful, this could show that a digital approach can expand access to genetic testing for people at higher risk of BRCA-related cancers.
What could go wrong: This is an observational study focused on feasibility and access, not on treatment. It may not lead to direct health improvements, and results may not apply to other populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BRCA1 MUTATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BRCA1 MUTATION BRCA2 MUTATION

Contacts and locations

Locations

Beth Israel Deaconess Medical Center

Boston, Massachusetts, 02215, United States
Dana Farber Cancer Institute

Boston, Massachusetts, 02115, United States
Memorial Sloan - Kettering Cancer Center

New York, New York, 10021, United States
University of California, Los Angeles

Los Angeles, California, 90095, United States
University of Pennsylvania

Philadelphia, Pennsylvania, 19104-4283, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.